Phytor Ltd

Phytor Ltd. specializes in providing regulatory and product development advice to importers and manufacturers of biopharmaceutical and food products. Our staff consists of experts in regulatory affairs product formulation, manufacturing and testing, pharmacology-toxicology, statistics, medicinal chemistry of natural products including cannabinoids, clinical trial design and evaluation and GMP (Israeli ministry of health) regulatory compliance. Possessing an extensive biopharmaceutical product experience, we at Phytor Ltd are thus able to offer consulting services and regulatory support based on a full understanding of regulatory expectations and policies. Capabilities: Phytor Lab for Drug Development possess state-of-the-art instruments and equipment enabling the following activities: Development of novel small molecule drugs derived from medicinal plants for the treatment of several cancers and neurodegenerative diseases. Development of medical devices for early diagnostic of neurodegenerative diseases. Development of novel antimicrobial agents based on products of natural origin and their use in food industry and medical devices market, as well as development of tailored assays in microbiology. Techniques used in our lab include: Cell and Molecular Biology - Biochemistry • FACS • Cell Viability - MTT • qRT-PCR • Western blotting • Cell Transfection - Immunodepletion • Migration, Invasion and Cell Proliferation Assays • Microscopy (Fluorescence, confocal and phase contrast) Analytical Chemistry – High Performance Liquid Chromatography (HPLC) Gas Chromatography (GC) Mass Spectrometry (MS) Infrared Spectroscopy (IR) Areas of interest for R&D include: Cancer; Neurodegenerative Diseases; Phytochemistry; Cell and Molecular Biology. We also perform assays in Toxicology – In vitro and In vivo; Organic Synthesis – Medicinal Chemistry and Immunology Assays.